[HTML][HTML] Plasmodium falciparum resistance to artemisinin-based combination therapies

KE Ward, DA Fidock, JL Bridgford - Current opinion in microbiology, 2022 - Elsevier
Highlights•Mutant K13-mediated artemisinin resistance involves reduced hemoglobin
endocytosis.•Artemisinin partial resistance has emerged in Africa.•Novel PfCRT mutations …

Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa

PJ Rosenthal, V Asua, MD Conrad - Nature Reviews Microbiology, 2024 - nature.com
Malaria, mostly due to Plasmodium falciparum infection in Africa, remains one of the most
important infectious diseases in the world. Standard treatment for uncomplicated P …

Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea

S Mihreteab, L Platon, A Berhane… - … England Journal of …, 2023 - Mass Medical Soc
Background Although the clinical efficacy of antimalarial artemisinin-based combination
therapies in Africa remains high, the recent emergence of partial resistance to artemisinin in …

Evolution of partial resistance to artemisinins in malaria parasites in Uganda

MD Conrad, V Asua, S Garg… - … England Journal of …, 2023 - Mass Medical Soc
Abstract Background Partial resistance of Plasmodium falciparum to the artemisinin
component of artemisinin-based combination therapies, the most important malaria drugs …

Evidence of artemisinin-resistant malaria in Africa

B Balikagala, N Fukuda, M Ikeda… - … England Journal of …, 2021 - Mass Medical Soc
Abstract Background In the six Southeast Asian countries that make up the Greater Mekong
Subregion, Plasmodium falciparum has developed resistance to derivatives of artemisinin …

Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic …

A Uwimana, N Umulisa, M Venkatesan… - The Lancet Infectious …, 2021 - thelancet.com
Background Partial artemisinin resistance is suspected if delayed parasite clearance (ie,
persistence of parasitaemia on day 3 after treatment initiation) is observed. Validated …

Malaria in 2022: Increasing challenges, cautious optimism

P Jagannathan, A Kakuru - Nature communications, 2022 - nature.com
Malaria cases and deaths remain unacceptably high and are resurgent in several settings,
though recent developments inspire optimism. This includes the approval of the world's first …

Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda

PK Tumwebaze, MD Conrad, M Okitwi, S Orena… - Nature …, 2022 - nature.com
Artemisinin partial resistance may facilitate selection of Plasmodium falciparum resistant to
combination therapy partner drugs. We evaluated 99 P. falciparum isolates collected in 2021 …

Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness

BH Stokes, SK Dhingra, K Rubiano, S Mok, J Straimer… - Elife, 2021 - elifesciences.org
The emergence of mutant K13-mediated artemisinin (ART) resistance in Plasmodium
falciparum malaria parasites has led to widespread treatment failures across Southeast …

[图书][B] World malaria report 2023

World Health Organization - 2023 - books.google.com
Page 1 World malaria וייוייו report 2023 wwwwww World Health Organization Page 2 World
malaria report 2023 ISBN 978-92-4-008617-3 (electronic version) ISBN 978-92-4-008618-0 …